U.S. stocks are moving differently | novo-nordisk a/s rises 2% pre-market, india team urges for the early launch of Wegovy.
Great Wall December 3rd | Novo Nordisk (NVO.US) pre-market trading up 2% on the US stock market. In terms of news, due to concerns about falling behind competitor Eli Lilly in the huge potential market of India, the Indian team of the Danish pharmaceutical giant Novo Nordisk has been pushing the company to launch its popular weight loss drug Wegovy in India earlier. (Great Wall)
Market Chatter: Novo Nordisk's India Unit Reportedly Pushes for Earlier Wegovy Launch
Concerned about falling behind eli lilly and co (LLY.US) and novo-nordisk a/s (NVO.US), the indian team urges an early launch of Wegovy in india.
Due to concerns about falling behind its competitor eli lilly and co in the potential huge market of india, the Indian team of the Danish pharmaceutical giant novo-nordisk a/s has been pushing the company to launch its popular weight loss drug Wegovy in india earlier.
Novo Nordisk (NVO) Among the Most Profitable Pharmaceutical Stocks Right Now
10 Health Care Stocks With Whale Alerts In Today's Session
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading